Table 3.
Drug/drug group | Agreement on clinical significance | Most common actions taken | Other comments |
---|---|---|---|
PPI |
Yes |
Reduce dose |
While it is clinically significant, it is also a cost control concern |
Stop medication | |||
Corticosteroids |
Yes |
Add medication |
|
Long-term, long-acting benzodiazepines |
Yes |
Switch to alternative |
Patient preference is an important factor. Availability of other services such as cognitive behavioural therapy is an important factor |
Reduce dose | |||
NSAID |
Yes |
Stop medication |
|
Switch to alternative | |||
Bladder antimuscarinics |
No |
Leave unaltered |
Patient preference is an important factor. Lack of good alternative options available |
Switch to alternative | |||
Tricyclic anti-depressants |
No |
Leave unaltered |
Patient preference is an important factor |
Switch to alternative | |||
Reduce dose | |||
Therapeutic duplications |
Yes |
Stop medication |
|
Switch to alternative | |||
Calcium channel blocker |
No |
Switch to alternative |
|
Theophylline | Yes | Stop medication |
Abbreviations: NSAID Nonsteroidal anti-inflammatory drug, PPI Proton pump inhibitor.